Boston Therapeutics, Inc. (OTCQB:BTHE)
Pharmaceutical ManufacturingMassachusetts, United States2-10 Employees
Boston Therapeutics, Inc. (BTI) is an innovator of novel therapies and diagnostics for unmet medical needs, some that may disrupt the existing marketplace. Our mission at BTI is to innovate and discover new technologies, and through patents and clinical development, to obtain marketing authorization for worldwide commercialization and application. BTI has operating centers worldwide, including China, supported by experienced teams of scientists, clinicians, regulatory affairs and business specialists. The main area of development that BTI has dedicated its efforts is metabolism. BTI aims to launch in the coming 3 years, 2-3 preventive and therapeutic products of enhanced efficacy to provide better patient care, target major markets including US and China where metabolism disorders are preponderant, social burden is significant and the unmet medical challenges are the greatest. One of our products is SugarDown, a chewable dietary supplement made from natural ingredients that blocks sugar, carbs, and calories from being absorbed into your system. You can find that product at www.sugardown.com
1-888-653-2347 
support@leadiq.com 
